Case Report: First-Line Immune Checkpoint Inhibitor Plus Chemotherapy for Oral Metastasis in a Patient with Ultra High-Risk Gestational Choriocarcinoma

References

• Schrader E, Stephens AJ, Shroff S, et al. Widespread choriocarcinoma metastases from de-differentiated gastro-esophageal junction primary adenocarcinoma: a case report with literature review. Gynecol Oncol Rep. 2019;31:100513. doi:10.1016/j.gore.2019.100513
   PubMed Web of Science ®Google Scholar
• Kösem M, Cankaya H, Kaya Z. Choriocarcinoma metastatic to mandibular gingiva: case report and review of metastatic gingival tumours. J Otolaryngol. 2004;33(5):310–314. doi:10.2310/7070.2004.03094
   PubMedGoogle Scholar
• Bakeen G, Hiyarat AM, Al-Ubaidy SS. Chorioepithelioma presenting as a bleeding gingival mass. Oral Surg Oral Med Oral Pathol. 1976;41(4):467–471. doi:10.1016/0030-4220(76)90274-7
   PubMedGoogle Scholar
• Altintas A, Vardar MA, Aridoğan N, et al. Choriocarcinoma metastatic to the maxillary gingiva. Eur J Surg Oncol. 1995;21(5):579–580. doi:10.1016/s0748-7983(95)97712-0
   PubMedGoogle Scholar
• Shafiee MN, Ismail NM, Shan LP, et al. A case report: metastatic choriocarcinoma to the gum. Sex Reprod Healthc. 2011;2(2):91–92. doi:10.1016/j.srhc.2011.02.001
   PubMed Web of Science ®Google Scholar
• Khanfir A, Kaffel T, Gouiaa N, et al. Primary choriocarcinoma of the maxillary gingival. Rev Stomatol Chir Maxillofac. 2012;113(5):382–384. doi:10.1016/j.stomax.2011.12.001
   PubMedGoogle Scholar
• Velasco I, Aguilar L, Pastrian J, et al. Gingival metastasis from a testicular choriocarcinoma: an unusual case report and review of the literature. Int J Morphol. 2013;31(1):140–143. doi:10.4067/S0717-95022013000100023
   Web of Science ®Google Scholar
• Scolozzi P, Marret N, Bouzourene H, et al. Mixed testicular germ cell tumor presenting as metastatic pure choriocarcinoma involving the maxillary gingiva. J Oral Pathol Med. 2006;35(9):579–581. doi:10.1111/j.1600-0714.2006.00443.x
   PubMed Web of Science ®Google Scholar
• Al-Husaini H, Soudy H, Darwish A, et al. Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience. Clin Transl Oncol. 2015;17(5):409–415. doi:10.1007/s12094-014-1251-1
   PubMed Web of Science ®Google Scholar
• Herbst RS, Baas P, Kim DW, et al. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet. 2016;387(10027):1540–1550. doi:10.1016/S0140-6736(15)01281-7
   PubMed Web of Science ®Google Scholar
• Abi Nahed R, Elkhoury Mikhael M, Reynaud D, et al. Role of NLRP7 in normal and malignant trophoblast cells. Biomedicines. 2022;10(2):252. doi:10.3390/biomedicines10020252
   PubMed Web of Science ®Google Scholar
• Reynaud D, Abi Nahed R, Lemaitre N, et al. NLRP7 promotes choriocarcinoma growth and progression through the establishment of an immunosuppressive microenvironment. Cancers. 2021;13(12):2999. doi:10.3390/cancers13122999
   PubMed Web of Science ®Google Scholar
• Clair KH, Gallegos N, Bristow RE. Successful treatment of metastatic refractory gestational choriocarcinoma with pembrolizumab: a case for immune checkpoint salvage therapy in trophoblastic tumors. Gynecol Oncol Rep. 2020;34:100625. doi:10.1016/j.gore.2020.100625
   PubMed Web of Science ®Google Scholar
• Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet. 2010;376(9742):717–729. doi:10.1016/S0140-6736(10)60280-2
   PubMed Web of Science ®Google Scholar
• Nakazaki H, Tokuyasu H, Takemoto Y, et al. Pulmonary metastatic choriocarcinoma from a burned-out testicular tumor. Intern Med. 2016;55(11):1481–1485. doi:10.2169/internalmedicine.55.5679
   PubMed Web of Science ®Google Scholar
• Owosho AA, Xu B, Kadempour A, et al. Metastatic solid tumors to the jaw and oral soft tissue: a retrospective clinical analysis of 44 patients from a single institution. J Craniomaxillofac Surg. 2016;44(8):1047–1053. doi:10.1016/j.jcms.2016.05.013
   PubMed Web of Science ®Google Scholar
• Tsuge S, Shibata K, Yamamoto H. Case of metastasis to the gingiva of chorioepithelioma malignum. Iryo. 1962;16:196–197.
   PubMedGoogle Scholar
• Roa HS, Mizrahi SJ. Choriocarcinoma of the testicle with metastasis to the gingiva (report of a case). Rev Guatem Estomatol. 1972;2(3):96–99.
   PubMedGoogle Scholar
• Mori M, Amano Y, Sakamoto M, et al. A case of metastatic choriocarcinoma of the gingiva (author’s transl). Nihon Koku Geka Gakkai Zasshi. 1974;20(6):621–626.
   PubMedGoogle Scholar
• Nespeca JA, Sass JK. Choriocarcinoma metastatic to maxillary gingiva. J Oral Surg. 1980;38(7):534–537.
   PubMedGoogle Scholar
• Bhatia K, Vaid AK, Rawal S, et al. Pure choriocarcinoma of testis with rare gingival and skin metastases. Singapore Med J. 2007;48(3):e77–e80.
   PubMedGoogle Scholar
• Nishimura Y, Yakata H, Kawasaki T, et al. Metastatic tumours of the mouth and jaws. A review of the Japanese literature. J Maxillofac Surg. 1982;10(4):253–258. doi:10.1016/s0301-0503(82)80050-7
   PubMed Web of Science ®Google Scholar
• Sato M, Nishio J, Yoshida H, et al. Metastatic choriocarcinoma involving the gingiva. Int J Oral Surg. 1978;7(3):192–196. doi:10.1016/s0300-9785(78)80024-6
   PubMedGoogle Scholar
• Sebire NJ, Lindsay I. Current issues in the histopathology of gestational trophoblastic tumors. Fetal Pediatr Pathol. 2010;29(1):30–44. doi:10.3109/15513810903266120
   PubMed Web of Science ®Google Scholar
• Auguste P, Fallavollita L, Wang N, et al. The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation. Am J Pathol. 2007;170(5):1781–1792. doi:10.2353/ajpath.2007.060886
   PubMed Web of Science ®Google Scholar
• Lurain JR, Singh DK, Schink JC. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy. J Reprod Med. 2006;51(10):767–772.
   PubMed Web of Science ®Google Scholar
• Zong L, Yang J, Wang X, et al. Management and prognosis of patients with liver metastases from gestational trophoblastic neoplasia: a retrospective cohort study. Cancer Manag Res. 2018;10:557‑563. doi:10.2147/CMAR.S160606
   PubMed Web of Science ®Google Scholar
• Ngan HYS, Seckl MJ, Berkowitz RS, et al. Diagnosis and management of gestational trophoblastic disease: 2021 update. Int J Gynaecol Obstet. 2021;155 Suppl 1(S1):86–93. doi:10.1002/ijgo.13877
   PubMed Web of Science ®Google Scholar
• Huang M, Pinto A, Castillo RP, et al. Complete serologic response to pembrolizumab in a woman with chemoresistant metastatic Choriocarcinoma. J Clin Oncol. 2017;35(27):3172–3174. doi:10.1200/JCO.2017.74.4052
   PubMed Web of Science ®Google Scholar
• Brewer JI, Torok EE, Kahan BD, et al. Gestational trophoblastic disease: origin of choriocarcinoma, invasive mole and choriocarcinoma associated with hydatidiform mole, and some immunologic aspects. Adv Cancer Res. 1978;27:89–147. doi:10.1016/s0065-230x(08)60931-8
   PubMedGoogle Scholar
• Ghorani E, Kaur B, Fisher RA, et al. Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia. Lancet. 2017;390(10110):2343–2345. doi:10.1016/S0140-6736(17)32894-5
   PubMed Web of Science ®Google Scholar
• Paspalj V, Polterauer S, Poetsch N, et al. Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: a case report. Gynecol Oncol Rep. 2021;37:100817. doi:10.1016/j.gore.2021.100817
   PubMed Web of Science ®Google Scholar